Alterity Therapeutics Files 6-K, Reports Substantial Holder Change
Ticker: PRNAF · Form: 6-K · Filed: Mar 25, 2025 · CIK: 1131343
| Field | Detail |
|---|---|
| Company | Alterity Therapeutics Ltd (PRNAF) |
| Form Type | 6-K |
| Filed Date | Mar 25, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 6-K, substantial-holder, corporate-action
Related Tickers: ATHE
TL;DR
Alterity Therapeutics (ATHE) filed a 6-K showing a substantial holder is no longer a major player.
AI Summary
Alterity Therapeutics Ltd. filed a Form 6-K on March 25, 2025, to report its activities for March 2025. This filing includes an exhibit titled 'Ceasing to be a substantial holder'. The company is a development stage enterprise and is incorporated in Australia.
Why It Matters
This filing indicates a change in significant ownership, which could signal shifts in investor confidence or strategic direction for the company.
Risk Assessment
Risk Level: medium — Form 6-K filings often contain updates on corporate actions or regulatory matters that can impact stock price, and changes in substantial holders can be a significant event.
Key Players & Entities
- ALTERITY THERAPEUTICS LTD (company) — Registrant
- PRANA BIOTECHNOLOGY LTD (company) — Former Company Name
- March 2025 (date) — Reporting Period
- 20250325 (date) — Filing Date
FAQ
What is the primary purpose of this Form 6-K filing?
The Form 6-K is a report of foreign private issuer for the month of March 2025, and it includes an exhibit regarding ceasing to be a substantial holder.
What is the company's former name?
The company's former name was PRANA BIOTECHNOLOGY LTD.
When was the company's name changed?
The date of the name change was January 5, 2001.
Is Alterity Therapeutics filing annual reports under Form 20-F or 40-F?
Alterity Therapeutics indicates it files annual reports under Form 20-F.
What exhibit is included with this 6-K filing?
Exhibit 99.1, titled 'Ceasing to be a substantial holder', is submitted with this 6-K filing.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on March 25, 2025 regarding ALTERITY THERAPEUTICS LTD (PRNAF).